Lauranne Piron
Overview
Explore the profile of Lauranne Piron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monet C, De Jong A, Aarab Y, Piron L, Prades A, Carr J, et al.
Crit Care
. 2022 Sep;
26(1):282.
PMID: 36123713
Background: Molecular Adsorbent Recirculating System (MARS®) is a non-biological artificial liver device. The benefit risk ratio between uncertain clinical effects and potential adverse events remains difficult to assess. We sought...
2.
Minier C, Hermida M, Allimant C, Escal L, Pierredon-Foulongne M, Belgour A, et al.
Diagn Interv Imaging
. 2022 Mar;
103(5):240-250.
PMID: 35246412
Purpose: The purpose of this study was to make a systematic review of clinical studies evaluating software-based tumor margin assessment after percutaneous thermoablation (PTA) of liver tumors. Materials And Methods:...
3.
Hermida M, Preel A, Assenat E, Piron L, Cassinotto C, Ursic-Bedoya J, et al.
Hepatol Commun
. 2021 Apr;
5(4):689-700.
PMID: 33860126
Percutaneous thermal ablation is a validated treatment option for small hepatocellular carcinoma (HCC). Steatotic HCC can be reliably detected by magnetic resonance imaging. To determine the clinical relevance of this...
4.
Piron L, Deshayes E, Cassinotto C, Quenet F, Panaro F, Hermida M, et al.
Diagnostics (Basel)
. 2020 Dec;
11(1).
PMID: 33374810
The objective was to assess the changes in regional volumes and functions under venous-impaired vascular conditions following liver preparation. Twelve patients underwent right portal vein embolization (PVE) ( = 5)...
5.
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, De Baere T, et al.
Lancet Gastroenterol Hepatol
. 2020 Nov;
6(1):17-29.
PMID: 33166497
Background: All randomised phase 3 studies of selective internal radiation therapy for advanced hepatocellular carcinoma published to date have reported negative results. However, these studies did not use personalised dosimetry....
6.
Guiu B, Quenet F, Panaro F, Piron L, Cassinotto C, Herrerro A, et al.
Hepatobiliary Surg Nutr
. 2020 Nov;
9(5):564-576.
PMID: 33163507
Background: We previously showed that embolization of portal inflow and hepatic vein (HV) outflow (liver venous deprivation, LVD) promotes future liver remnant (FLR) volume (FLR-V) and function (FLR-F) gain. Here,...
7.
Deshayes E, Piron L, Bouvier A, Lapuyade B, Lermite E, Vervueren L, et al.
BMC Cancer
. 2020 Jun;
20(1):574.
PMID: 32560632
Background: In patients undergoing major liver resection, portal vein embolization (PVE) has been widely used to induce hypertrophy of the non-embolized liver in order to prevent post-hepatectomy liver failure. PVE...
8.
Cassinotto C, Lapuyade B, Guiu B, Marraud des Grottes H, Piron L, Merrouche W, et al.
Clin Gastroenterol Hepatol
. 2020 Apr;
18(13):2971-2979.e3.
PMID: 32348907
Background & Aims: Inter-platform variation in liver stiffness evaluation (LSE) could hinder dissemination and clinical implementation of new ultrasound methods. We aimed to determine whether measurements of liver stiffness by...
9.
Nougaret S, Monsonis B, Molinari N, Riviere B, Piron L, Kassam Z, et al.
Eur Radiol
. 2020 Apr;
30(9):4752-4761.
PMID: 32318848
Objectives: To quantify and compare the fat fraction of background liver and primary liver lesions using a triple-echo-gradient-echo sequence. M&M: This IRB-approved study included 128 consecutive patients who underwent a...
10.
Hermida M, Cassinotto C, Piron L, Aho-Glele S, Guillot C, Schembri V, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32013112
Background: To identify the predictive factors of recurrence and survival in an unselected population of Western patients who underwent multimodal percutaneous thermal ablation (PTA) for small Hepatocellular Carcinomas (HCCs). Methods:...